Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LUCY-1: Letermovir + Valganciclovir for CMV in Kidney Transplant Recipients
NCT06334497Phase 3Recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Aug 2024
- Primary completion
- Sep 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of letermovir in cytomegalovirus infection (CMV), sponsored by Assistance publique - Hôpitaux de Paris. Started Aug 2024; status: recruiting.
02
Drugs
letermovir
03
Conditions
cytomegalovirus infection (CMV)
Beyond the preview
Go deeper on NCT06334497.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06334497.